Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLDEN-5: SUN-101 Safety in COPD
NCT02276222Phase 3Completed
- Sponsor
- Sunovion
- Start
- Oct 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of glycopyrrolate metered dose inhaler in chronic obstructive pulmonary disease (COPD), sponsored by Sunovion. Started Oct 2014; status: completed.
02
Drugs
glycopyrrolate metered dose inhaler
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02276222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276222.